Acellera’s Collaborations Clause Samples

Acellera’s Collaborations. Since the beginning of the project, Acellera participated in the dissemination of the project news and promoted the use of in silico methods in industry and non-profit entities by participating and organising events, but especially by its effective marketing activity (during national and international events, such as congresses, and through their channels of digital marketing, such as Acellera website, LinkedIn and Twitter). This activity is illustrated by the organisation of workshops, its participation in workshops and its participation in various events and webinar (see Section 6.1.3). Acellera’s ISBA protocol has been optimized and is ready to initiate collaboration among CompBioMed partners. Discussions with CompBioMed partners ▇▇▇▇▇▇ and ▇▇▇▇▇▇▇ were started to define the systems to study, the approach to consider, and the legal aspects when sharing technological or scientific knowledge among partners. Since simulations depend on the choice of molecule, emphasis has been put on the development of the protocol, particularly the sampling protocol (e.g.: Adaptive sampling, Adaptive Goal sampling) and its deployment to scale-up the simulations (clusters and Cloud). Today, these protocols are implemented in the software provided by Acellera and used both for services and internal research projects at Acellera. They demonstrated their robustness when predicting ligand binding site and reproducing the binding pathway and have proved to be applicable to a wide range of biomolecules. Moreover, Acellera provides free access through its platform ▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇ to promote the use of in silico methods for drug discovery and molecular medicine projects (see statistics shared elsewhere). This platform encountered a large success since its release in June 2017. Between June 2017 and March 2019, the number of visits reached 16000 distributed including some 85% of non-profit entities’ users and 15% of industrial users, not only from large pharmaceutical companies but also SMEs. Several contacts were established with both large pharmaceutical companies and SMEs, showing a clear interest for the platform but also demonstrating the potential of the platform for visibility, testing and validating the interest for new applications or software in biomedicine. In order to propose a larger offering and more power for Cloud Computing, Acellera contacted CompBioMed’s Associate Partner Microsoft Azure. A recent (December 2018) collaboration has been set in order to promote Ace...
View Source

Related to Acellera’s Collaborations

  • Research Collaboration Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.

  • Collaboration activities 4.1 The Collaboration Suppliers will perform the Collaboration Activities and all other obligations of this Agreement in accordance with the Detailed Collaboration Plan. 4.2 The Collaboration Suppliers will provide all additional cooperation and assistance as is reasonably required by the Buyer to ensure the continuous delivery of the services under the Call-Off Contract. 4.3 The Collaboration Suppliers will ensure that their respective subcontractors provide all cooperation and assistance as set out in the Detailed Collaboration Plan.

  • Scope of Collaboration As part of the collaboration, the Controllers will act as Joint Controller. The roles of the Controller and the associated tasks are specified in more detail in Appendix 1. If one party is solely responsible for a data processing operation, this party will implement all relevant data protection provisions on its own responsibility. However, such data processing procedures are not subject to this Agreement. Joint data processing and the type of Personal Data collected and processed within the framework of collaboration are specified in Appendix 1.

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.